Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antiepileptic agents.

Linda P Nelson1, Ilse Savelli-Castillo

  • 1Department of Pediatric Dentistry, Children 's Hospital, Boston, Mass, USA.

Pediatric Dentistry
|April 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing dental fear in children with autism spectrum disorders: a randomized controlled pilot study using electronic screen media.

Clinical pediatrics·2014
Same author

A performance measurement plan for pediatric dentists: using accuracy of caries diagnosis from intraoral radiographs.

Pediatric dentistry·2013
Same author

Unmet dental needs and barriers to care for children with significant special health care needs.

Pediatric dentistry·2011
Same author

Dental manifestations associated with Seckel syndrome type II: a case report.

Pediatric dentistry·2010
Same author

Accuracy of familial reporting of a child's medical history in a dental clinic setting.

Pediatric dentistry·2004
Same author

Assess ABCD to ascertain the level of cultural influence in pediatric dental families.

Pediatric dentistry·2003
Same journal

Age-Specific Radiation Dose Distributions in Pediatric Intraoral Radiography: A Monte Carlo Analysis Across Developmental Stages.

Pediatric dentistry·2026
Same journal

Protecting Advocacy's Clout.

Pediatric dentistry·2026
Same journal

Trends in the Emergence of Permanent Dentition: A Retrospective Analysis of Adolescents From 1980 to 2020.

Pediatric dentistry·2026
Same journal

The Perceived Impact of California Sedation Legislation on Clinical Practices in Pediatric Dentistry.

Pediatric dentistry·2026
Same journal

Evaluation of Breastfeeding and Formula Feeding on Childhood Caries Experience: National Health and Nutrition Examination Survey, 2015-2018.

Pediatric dentistry·2026
Same journal

Comparative Evaluation of Compressive Strength, Microhardness, and Wear Resistance in Preformed Resin Polymer, Stainless Steel, and Zirconia Crowns.

Pediatric dentistry·2026
See all related articles

Seven new antiepileptic drugs (AEDs) approved since 1993 offer improved treatment for refractory childhood epilepsy. These medications provide better outcomes for about 25% of pediatric patients previously unresponsive to traditional therapies.

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Epilepsy treatment in children has seen limited advancements for many years.
  • The US Food and Drug Administration (FDA) has approved new antiepileptic drugs (AEDs) starting in 1993.
  • A significant portion of pediatric patients remain refractory to conventional antiepileptic drug therapies.

Purpose of the Study:

  • To provide an update on new antiepileptic drugs (AEDs) for the pediatric population.
  • To summarize the efficacy and side effects of newly approved AEDs in children.
  • To inform pediatric dentists about advancements in childhood epilepsy treatment.

Main Methods:

  • Review of recent US FDA approvals for antiepileptic drugs (AEDs).
  • Summary of available information on the efficacy of new AEDs in pediatric patients.

Related Experiment Videos

  • Compilation of data on the side effect profiles of these new AEDs in children.

    • Main Results:

    • Seven new AEDs have been introduced in the United States since 1993.
    • These new AEDs offer more successful treatment outcomes for approximately 25% of pediatric patients with refractory epilepsy.
    • The new AEDs include felbamate, gabapentin, lamotrigine, topiramate, tiagabine, vigabatrin, and oxcarbazepine.

    Conclusions:

    • Recent FDA-approved AEDs represent a significant therapeutic improvement for childhood epilepsy.
    • Newer antiepileptic drugs provide viable options for pediatric patients who do not respond to older medications.
    • Understanding the efficacy and side effects of these AEDs is crucial for managing pediatric epilepsy.